Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30920079)

  • 1. Expression analysis of selected miR-206 targets from the transforming growth factor-β signaling pathway in breast cancer.
    Seifi-Alan M; Dianatpour A; Geranpayeh L; Mirfakhraie R; Omrani MD; Ghafouri-Fard S
    J Cell Biochem; 2019 Aug; 120(8):13545-13553. PubMed ID: 30920079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells.
    Yin K; Yin W; Wang Y; Zhou L; Liu Y; Yang G; Wang J; Lu J
    Oncotarget; 2016 Apr; 7(17):24537-48. PubMed ID: 27014911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of long non-coding ATB and its putative target in breast cancer.
    Nikpayam E; Soudyab M; Tasharrofi B; Sarrafzadeh S; Iranpour M; Geranpayeh L; Mirfakhraie R; Gharesouran J; Ghafouri-Fard S
    Breast Dis; 2017; 37(1):11-20. PubMed ID: 28598827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression.
    Hou LK; Yu Y; Xie YG; Wang J; Mao JF; Zhang B; Wang X; Cao XC
    Oncotarget; 2016 May; 7(18):26016-26. PubMed ID: 27036021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIR-27a regulates the TGF-β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
    Chae DK; Ban E; Yoo YS; Kim EE; Baik JH; Song EJ
    Mol Carcinog; 2017 Aug; 56(8):1992-1998. PubMed ID: 28370334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
    Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception of breast cancer risk factors: Dysregulation of TGF-β/miRNA axis in Pakistani females.
    Ahmed F; Adnan M; Malik A; Tariq S; Kamal F; Ijaz B
    PLoS One; 2021; 16(7):e0255243. PubMed ID: 34297787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1 regulating miR-205/miR-195 expression affects the TGF-β signal pathway by respectively targeting SMAD2/SMAD7.
    Duan Y; Chen Q
    Oncol Rep; 2016 Oct; 36(4):1837-44. PubMed ID: 27574009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
    Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
    Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
    J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
    Figueroa JD; Flanders KC; Garcia-Closas M; Anderson WF; Yang XR; Matsuno RK; Duggan MA; Pfeiffer RM; Ooshima A; Cornelison R; Gierach GL; Brinton LA; Lissowska J; Peplonska B; Wakefield LM; Sherman ME
    Breast Cancer Res Treat; 2010 Jun; 121(3):727-35. PubMed ID: 19937272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels.
    Petrovic N; Davidovic R; Jovanovic-Cupic S; Krajnovic M; Lukic S; Petrovic M; Roganovic J
    Mol Diagn Ther; 2016 Dec; 20(6):603-615. PubMed ID: 27488105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells.
    Langer EM; Kendsersky ND; Daniel CJ; Kuziel GM; Pelz C; Murphy KM; Capecchi MR; Sears RC
    Oncogene; 2018 Feb; 37(8):1005-1019. PubMed ID: 29084210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway.
    Xie R; Tang J; Zhu X; Jiang H
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30979827
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer.
    Dashti S; Ghafouri-Fard S; Esfandi F; Oskooei VK; Arsang-Jang S; Taheri M
    Exp Mol Pathol; 2020 Feb; 112():104359. PubMed ID: 31837323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
    Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
    Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.
    Pollari S; Leivonen SK; Perälä M; Fey V; Käkönen SM; Kallioniemi O
    PLoS One; 2012; 7(5):e37361. PubMed ID: 22629385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microRNA-141-3p/ CDK8 pathway regulates the chemosensitivity of breast cancer cells to trastuzumab.
    Song W; Wu S; Wu Q; Zhou L; Yu L; Zhu B; Gong X
    J Cell Biochem; 2019 Aug; 120(8):14095-14106. PubMed ID: 31087707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.